AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
The Cybersecurity and Infrastructure Security Agency (CISA) is warning that hackers are actively exploiting a critical ...